Search: Look for:   Last 1 Month   Last 6 Months   All time

Cancer drug: Natco Pharma told to file reply by Aug 25

Tamil Nadu,Business/Economy,Immigration/Law/Rights, Tue, 21 Aug 2012 IANS

Chennai, Aug 21 (IANS) The Intellectual Property Appellate Board (IPAB) Tuesday asked the Hyderabad-based Natco Pharma to reply by Aug 25 on Bayer Corp's plea against the issuance of licence to it to sell the generic equivalent of Bayer's cancer drug Nexavar.

The board adjourned the hearing to the first week of the next month while declining to impose any costs on Natco Pharma for not filing its reply till date. It also refused to order a stay on the latter's licence to make and sell generic cancer drug sorafenib tosylate.

Bayer Corp, the north American subsidiary of German company Bayer AG, filed the petition challenging the March order of the Controller General of Patents, Designs and Trade Marks of compulsorily licensing Natco Pharma to market the generic version of Nexavar.

Bayer filed the petition against Natco Pharma, the controller of general patents and the central government.

Incidentally, this was the first time that the compulsory licence provision in the Indian Patent Act was invoked in India.

Bayer's drug costs around Rs.280,000 for a month's course whereas Natco Pharma sells the same for around Rs.8,000 for a month's course.

Arguing for Bayer, senior counsel Sudhir Chandra said the licence given to Natco Pharma had international ramifications and had caused severe injury to his client.

He said another pharma company, Cipla, was also selling the same drug at around Rs.5,000 for a month's course.

Later speaking to reporters, Chandra said: "The court has taken note of the fact that injury is caused to Bayer. They will not grant any more time to Natco to file its reply. Natco has to file its reply by Aug 25."

Speaking to IANS by phone from New Delhi, Natco Pharma's counsel Rajeshwari Hariharan said the replies will be filed by Aug 25.

She said many countries like Canada, Brazil, Thailand and others had similar compulsory licensing provisions and India was not an exception.

Manohar Lal being presented with a memento
Manoj Tiwari BJP Relief meets the family members of late Ankit Sharma
Haryana CM Manohar Lal congratulate former Deputy PM Lal Krishna Advani on his 92nd birthday
King of Bhutan, the Bhutan Queen and Crown Prince meeting the PM Modi
PM Narendra Modi welcomes the King of Bhutan
Post comments:
Your Name (*) :
Your Email :
Your Phone :
Your Comment (*):
  Reload Image




Excellent Hair Fall Treatment
Careers | Privacy Policy | Feedback | About Us | Contact Us | | Latest News
Copyright © 2015 NEWS TRACK India All rights reserved.